Newsroom
January 25, 2017
Adding everolimus to fulvestrant improved progression-free survival (PFS) in postmenopausal women with hormone receptor (HR)-positive/HER2-negative, aromatase inhibitor (AI)-resistant metastatic breast cancer during the randomized, Phase II PrECOG 0102 trial. Read the full story at Clinical Oncology News
January 25, 2017
I’m part-way through Week Three of “Take Your Medicine — The Impact of Drug Development,” a free MOOC (massive open online course) offered by the University of Texas. Bottom line seems to be this: It costs a ton of money and requires a lot of work in the lab and the clinic before a drug […]
January 23, 2017
In 2014, the university experienced two large power outages, grabbing the attention of university leadership and the University of Texas System Board of Regents. The outages resulted in a renewed focus on addressing failing electrical infrastructure, a focus that continues today.
January 20, 2017
The following sentence might save someone’s life: There are millions of Americans with a serious, life-threatening virus that can be cured, within roughly 12 weeks — if they simply get tested and find out they have it. Read the full story at the Express-News
January 20, 2017
Cervical cancer has been topping medical headlines this week. Watch the full story at News 4
January 20, 2017
First the nursing students heard the tune of “Soul Man.” Then, as the music faded, a voice. Read the full story a the Express-News